Tmunity Stock

tmunity.comHealthcareFounded: 2015Funding to Date: $220.28MM

Tmunity is a clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy to patients with devastating diseases.

Register for Details

For more details on financing and valuation for Tmunity, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Tmunity.

Register Today

Team

Management Team

Graeme Bell
Chief Financial Officer & Executive Vice President
Michael Christiano
Executive Vice President and Chief Business Officer
Bruce Levine Ph.D
Co-Founder & Advisor
Usman Azam MD
President, Chief Executive Officer & Board Member
Christina Coughlin MD
Chief Medical Officer & Executive Vice President
Bruce Blazar MD
Co-Founder & Advisor
Yangbing Zhao Ph.D
Co-Founder & Advisor
Anne Chew Ph.D
Co-Founder, Advisor & Board Member
Jason Krentz
Chief Technology Officer & Head, Technical Operations
James Riley
Co-Founder & Advisor
Carl June MD
Co-Founder & Chief Scientific Advisor

Board Members

Patrick Gray
Anne Chew Ph.D
Usman Azam MD
Garry Nicholson

Other companies like Tmunity in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

Tmunity Therapeutics, a Philadelphia, PA-based T-cell immunotherapy company, closed a $75m Series B financing. The round was led by Andreessen Horowitz
Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of